National Action Plan For The MHPSS Response To COVID-19

National Action Plan for the MHPSS Response to COVID-19

This action plan was developed as part of the national response to the COVID-19 outbreak. It aims at comprehensively addressing the MHPSS aspects of the COVID-19 outbreak in Lebanon for all persons living in the country. It was developed by the MOPH-National Mental Health Programme (NMHP) with WHO and UNICEF, in line with the IASC Briefing note on addressing mental health and psychosocial aspects of COVID-19 Outbreak- version 1.0 and the local needs, health system and national mental health strategy.

Goals:

Promote mental health and mitigate COVID-19 related stressors including stigma and discrimination against persons affected and health workers.
Provide mental health support to the persons in quarantine in the hospital or at home and their families.
Support the mental health of health workers and first responders in the response.
Ensure continuity of mental health care for persons using mental health services in line with IPC guidelines.

To view the action plan, click here: National Action Plan for MHPSS Response to COVID-19

...

All

ATC	Name	B/G ↑	Ingredients	Dosage	Form	Price
D06BB10	ALDARA	B	Imiquimod - 5%	5%	Cream	6,301,277 L.L
S01EA05	ALPHAGAN P	B	Brimonidine tartrate - 1.5mg/ml	0.15%	Drops solution	999,819 L.L
S01EA05	ALPHAGAN P	B	Brimonidine tartrate - 1.5mg/ml	0.15%	Drops solution	999,819 L.L
N06DA02	ARICEPT	B	Donepezil HCl - 10mg	10mg	Tablet, film coated	3,776,197 L.L
A02AF02	ACTONORM	B	Aluminium hydroxide - 220mg/5ml, Magnesium hydroxide - 200mg/5ml, Simethicone - 25mg/5ml		Suspension	425,998 L.L
S01EA05	ALPHAGAN P	B	Brimonidine tartrate - 0.1%	0.15%	Drops solution	999,819 L.L
A10BG03	ACTOS	B	Pioglitazone HCl - 30mg	30mg	Tablet	2,484,765 L.L
S01EC04	AZOPT	B	Brinzolamide - 10mg/ml	10mg/ml	Drops suspension	804,962 L.L
A10BG03	ACTOS	B	Pioglitazone HCl - 15mg	15mg	Tablet	1,243,054 L.L
C02AB02	ALDOMET	B	Methyldopa - 250mg	250mg	Tablet, coated	644,400 L.L
C02AB02	ALDOMET	B	Methyldopa - 500mg	500mg	Tablet, coated	856,708 L.L
M04AA03	ADENURIC	B	Febuxostat - 120mg	120mg	Tablet, film coated	2,184,704 L.L
M04AA03	ADENURIC	B	Febuxostat - 80mg	80mg	Tablet, film-scored	2,127,111 L.L
M04AA03	ADENURIC	B	Febuxostat - 40mg	40mg	Tablet, film coated	1,687,866 L.L
D07AC14	ADVANTAN	B	Methylprednisolone aceponate - 1mg/g	1mg/g	Ointment	385,683 L.L
D07AC14	ADVANTAN	B	Methylprednisolone aceponate - 1mg/g	1mg/g	Cream	385,683 L.L
C02LA51	ADELPHAN ESIDREX	B	Reserpine - 0.1mg, Hydrochlorothiazide - 10mg, Dihydralazine - 10mg		Tablet	371,157 L.L
L01XK52	AKEEGA	B	Niraparib - 100mg, Abiraterone acetate - 500mg		Tablet, film coated	519,366,124 L.L
L01XK52	AKEEGA	B	Niraparib - 50mg, Abiraterone acetate - 500mg		Tablet, film coated	519,366,124 L.L
B01AX05	ARIXTRA	B	Fondaparinux sodium - 2.5mg/0.5ml	2.5mg/0.5ml	Injectable solution	5,341,774 L.L
J01CR02	AUGMENTIN	B	Amoxicillin (trihydrate) - 125mg/5ml, Clavulanic Acid (potassium) - 31.25mg/5ml	156.25mg/5ml	Powder for suspension	302,365 L.L
B01AX05	ARIXTRA	B	Fondaparinux sodium - 7.5mg/0.6ml	7.5mg/0.6ml	Injectable solution	12,004,668 L.L
J01CR02	AUGMENTIN	B	Amoxicillin (trihydrate) - 250mg/5ml, Clavulanic Acid (potassium) - 62.5mg/5ml	312.5mg/5ml	Powder for suspension	542,912 L.L
N02BG06	ACUPAN	B	Nefopam HCl - 20mg	20mg	Injectable solution	365,525 L.L
J01CR02	AUGMENTIN	B	Amoxicillin (trihydrate) - 400mg/5ml, Clavulanic Acid (potassium) - 57mg/5ml	457mg/5ml	Powder for suspension	524,099 L.L
A07EC02	ASACOL	B	Mesalazine - 400mg	400mg	Tablet, enteric coated	5,895,437 L.L
A07EC02	ASACOL	B	Mesalazine - 800mg	800mg	Tablet	6,833,439 L.L
J01CR02	AUGMENTIN ES	B	Amoxicillin (trihydrate) - 600mg/5ml, Clavulanic Acid (potassium) - 42.9mg/5ml	642.9mg/5ml	Powder for suspension	846,621 L.L
S01GX07	ALLERGODIL	B	Azelastine HCl - 0.5mg/ml	0.5mg/ml	Drops solution	709,549 L.L
A07EC02	ASACOL	B	Mesalazine - 500mg	500mg	Suppository	1,703,992 L.L

...